English

NOVADEL PHARMA INC

EDGAR

Quarterly report (10-Q) · filed 2011-11-01

66 filing records in this dataset, filed from 1998-01-09 to 2011-11-01. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

115 thousand Unit12

2011 Q3 · Unit12

Exact inputs and evidence

Revenue: 115000 Unit12 Source

Operating margin

-701.74%

2011 Q3 · %

Exact inputs and evidence

Operating Income: -807000 Unit12 Source
Revenue: 115000 Unit12 Source

Operating cash flow

-482 thousand Unit12

2011 Q3 · Unit12

Exact inputs and evidence

Operating Cash Flow: -1895000 Unit12 Source
Operating Cash Flow: -1413000 Unit12 Source

Cash and cash equivalents: 429 thousand Unit12 2011-09-30 Source
Exact value

429000 Unit12
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

121 thousand USD

2008-01-01 – 2008-12-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 121000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-11-01.

Financial data available through: 2010-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2010-12-31
Operating income: 7 of 11 periods available· newest 2010-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 11 of 11 periods available· newest 2010-12-31
Capital expenditure: 11 of 11 periods available· newest 2010-12-31
Total assets: 1 of 11 periods available· newest 2010-12-31
Total liabilities: 1 of 11 periods available· newest 2010-12-31
Current assets: 1 of 11 periods available· newest 2010-12-31
Current liabilities: 1 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+569.7%

Prior period

USD 422,000

2009-01-01 – 2009-12-31
Current period

USD 2.83 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

2826000 − 422000 = 2404000 USD

422000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
2826000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NOVADEL PHARMA INC · 2010-12-31 NOVADEL PHARMA INC (edgar:1043873) Year-over-year change in Revenue: 2404000 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2826000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#7932 Input fundies:Revenue: 422000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#7932
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.91 million

Prior period

−USD 7.58 million

2009-01-01 – 2009-12-31
Current period

−USD 2.67 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-2666000 − -7577000 = 4911000 USD

-7577000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-2666000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NOVADEL PHARMA INC · 2010-12-31 NOVADEL PHARMA INC (edgar:1043873) Year-over-year change in Net income: 4911000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2666000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9119 Input fundies:NetIncome: -7577000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9119
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.7 million

Prior period

−USD 1.58 million

2009-01-01 – 2009-12-31
Current period

−USD 3.28 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-3280000 − -1578000 = -1702000 USD

-1578000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-3280000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NOVADEL PHARMA INC · 2010-12-31 NOVADEL PHARMA INC (edgar:1043873) Year-over-year change in Operating cash flow: -1702000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3280000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9391 Input fundies:OperatingCashFlow: -1578000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9391
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
USD 0

Prior period

USD 0

2009-01-01 – 2009-12-31
Current period

USD 0

2010-01-01 – 2010-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
0 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NOVADEL PHARMA INC · 2010-12-31 NOVADEL PHARMA INC (edgar:1043873) Year-over-year change in Capital expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9437 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9437
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 2.83 million 100% of revenue
Operating costs Derived USD 5.79 million 205% of revenue
Operating income −USD 2.97 million −105% of revenue
Tax, interest and other Derived −USD 302,000 −11% of revenue
Net income −USD 2.67 million −94% of revenue

Cash

Operating cash flow −USD 3.28 million −116% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived −USD 3.28 million −116% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Operating loss: operating costs were 2,480% of revenue.
2009 Operating loss: operating costs were 1,544% of revenue.
2010 Operating loss: operating costs were 205% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	361000	8951000 Derived	-8590000	996000 Derived	-9586000	-5654000 Derived	Source 2008-01-01 – 2008-12-31: 361000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -8590000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -9586000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -5533000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 121000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	422000	6517000 Derived	-6095000	1482000 Derived	-7577000	-1578000 Derived	Source 2009-01-01 – 2009-12-31: 422000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -6095000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -7577000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -1578000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	2826000	5794000 Derived	-2968000	-302000 Derived	-2666000	-3280000 Derived	Source 2010-01-01 – 2010-12-31: 2826000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -2968000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -2666000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -3280000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.8M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-07-31	Revenue	282000	Revenue: 282000 Open source
20082008-12-31	Revenue	361000	Revenue: 361000 Open source
20092009-12-31	Revenue	422000	Revenue: 422000 Open source
20102010-12-31	Revenue	2826000	Revenue: 2826000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

569.7% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-07-31	Year over year	No prior comparable period	Revenue: 282000 Open source
20082008-12-31	Year over year	No prior comparable period	Revenue: 361000 Open source
20092009-12-31	Year over year	16.9%	Revenue: 422000 Open source Revenue: 361000 Open source
20102010-12-31	Year over year	569.7%	Revenue: 2826000 Open source Revenue: 422000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -105% 2010

Net margin -94.3% 2010

Free cash flow margin -116.1% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-07-31	Operating margin	-417.7%	Operating Income: -1178000 Open source Revenue: 282000 Open source
20082008-12-31	Operating margin	-2,379.5%	Operating Income: -8590000 Open source Revenue: 361000 Open source
20092009-12-31	Operating margin	-1,444.3%	Operating Income: -6095000 Open source Revenue: 422000 Open source
20102010-12-31	Operating margin	-105%	Operating Income: -2968000 Open source Revenue: 2826000 Open source
20012001-07-31	Net margin	-393.3%	Net Income: -1109000 Open source Revenue: 282000 Open source
20082008-12-31	Net margin	-2,655.4%	Net Income: -9586000 Open source Revenue: 361000 Open source
20092009-12-31	Net margin	-1,795.5%	Net Income: -7577000 Open source Revenue: 422000 Open source
20102010-12-31	Net margin	-94.3%	Net Income: -2666000 Open source Revenue: 2826000 Open source
20012001-07-31	Free cash flow margin	Not reported	Revenue: 282000 Open source
20082008-12-31	Free cash flow margin	-1,566.2%	Revenue: 361000 Open source Operating Cash Flow: -5533000 Open source Capital Expenditure: 121000 Open source
20092009-12-31	Free cash flow margin	-373.9%	Revenue: 422000 Open source Operating Cash Flow: -1578000 Open source Capital Expenditure: 0 Open source
20102010-12-31	Free cash flow margin	-116.1%	Revenue: 2826000 Open source Operating Cash Flow: -3280000 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.3M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-07-31	Operating cash flow	Not reported	No source recorded
20082008-12-31	Operating cash flow	-5533000	Operating Cash Flow: -5533000 Open source
20092009-12-31	Operating cash flow	-1578000	Operating Cash Flow: -1578000 Open source
20102010-12-31	Operating cash flow	-3280000	Operating Cash Flow: -3280000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3.3M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-07-31	Free cash flow	Unavailable	No source recorded
20082008-12-31	Free cash flow	-5654000	Operating Cash Flow: -5533000 Open source Capital Expenditure: 121000 Open source
20092009-12-31	Free cash flow	-1578000	Operating Cash Flow: -1578000 Open source Capital Expenditure: 0 Open source
20102010-12-31	Free cash flow	-3280000	Operating Cash Flow: -3280000 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-07-31	Liabilities / assets	Not reported	No source recorded
2008-12-31	Liabilities / assets	Not reported	No source recorded
2009-12-31	Liabilities / assets	Not reported	No source recorded
2010-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2001-07-31	Current assets / current liabilities	Not reported	No source recorded
2008-12-31	Current assets / current liabilities	Not reported	No source recorded
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
2010-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2001-08-01 – 2002-07-31	−USD 4.29 million Exact value Exact value: -4290000 USD 2001-08-01 – 2002-07-31: -4290000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2002-07-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -4290000 USD Concept: fundies:NetIncome Period: 2001-08-01 to 2002-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2002-07-31&surface=latest&period_type=duration&start=2001-08-01&unit=USD&dimensions= Input fundies:NetIncome: -4290000 USD (2001-08-01 to 2002-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-03-006568.txt#2842 The citation records this snapshot. The page link may show a newer release later.	−USD 1.87 million Exact value Exact value: -1871000 USD 2001-08-01 – 2002-07-31: -1871000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2002-07-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -1871000 USD Concept: fundies:OperatingCashFlow Period: 2001-08-01 to 2002-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2002-07-31&surface=latest&period_type=duration&start=2001-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1871000 USD (2001-08-01 to 2002-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-03-006568.txt#2858 The citation records this snapshot. The page link may show a newer release later.	USD 316,000 Exact value Exact value: 316000 USD 2001-08-01 – 2002-07-31: 316000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2002-07-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 316000 USD Concept: fundies:CapitalExpenditure Period: 2001-08-01 to 2002-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2002-07-31&surface=latest&period_type=duration&start=2001-08-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 316000 USD (2001-08-01 to 2002-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-03-006568.txt#2862 The citation records this snapshot. The page link may show a newer release later.	−USD 2.19 million Calculation and evidence -1871000 − 316000 USD Exact free cash flow: -2187000 USD 2001-08-01 – 2002-07-31: -1871000 USD · Inspect Operating Cash Flow · Source 2001-08-01 – 2002-07-31: 316000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2002-07-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -2187000 USD Concept: free-cash-flow Period: 2001-08-01 to 2002-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1871000 USD (2001-08-01 to 2002-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-03-006568.txt#2858 Input fundies:CapitalExpenditure: 316000 USD (2001-08-01 to 2002-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-03-006568.txt#2862 The citation records this snapshot. The page link may show a newer release later.
2003 2002-08-01 – 2003-07-31	−USD 6.96 million Exact value Exact value: -6956000 USD 2002-08-01 – 2003-07-31: -6956000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2003-07-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -6956000 USD Concept: fundies:NetIncome Period: 2002-08-01 to 2003-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2003-07-31&surface=latest&period_type=duration&start=2002-08-01&unit=USD&dimensions= Input fundies:NetIncome: -6956000 USD (2002-08-01 to 2003-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4202 The citation records this snapshot. The page link may show a newer release later.	−USD 4.32 million Exact value Exact value: -4320000 USD 2002-08-01 – 2003-07-31: -4320000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2003-07-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -4320000 USD Concept: fundies:OperatingCashFlow Period: 2002-08-01 to 2003-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2003-07-31&surface=latest&period_type=duration&start=2002-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4320000 USD (2002-08-01 to 2003-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4218 The citation records this snapshot. The page link may show a newer release later.	USD 389,000 Exact value Exact value: 389000 USD 2002-08-01 – 2003-07-31: 389000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2003-07-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 389000 USD Concept: fundies:CapitalExpenditure Period: 2002-08-01 to 2003-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2003-07-31&surface=latest&period_type=duration&start=2002-08-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 389000 USD (2002-08-01 to 2003-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4222 The citation records this snapshot. The page link may show a newer release later.	−USD 4.71 million Calculation and evidence -4320000 − 389000 USD Exact free cash flow: -4709000 USD 2002-08-01 – 2003-07-31: -4320000 USD · Inspect Operating Cash Flow · Source 2002-08-01 – 2003-07-31: 389000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2003-07-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -4709000 USD Concept: free-cash-flow Period: 2002-08-01 to 2003-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4320000 USD (2002-08-01 to 2003-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4218 Input fundies:CapitalExpenditure: 389000 USD (2002-08-01 to 2003-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4222 The citation records this snapshot. The page link may show a newer release later.
2004 2003-08-01 – 2004-07-31	−USD 6.34 million Exact value Exact value: -6341000 USD 2003-08-01 – 2004-07-31: -6341000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2004-07-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -6341000 USD Concept: fundies:NetIncome Period: 2003-08-01 to 2004-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2004-07-31&surface=latest&period_type=duration&start=2003-08-01&unit=USD&dimensions= Input fundies:NetIncome: -6341000 USD (2003-08-01 to 2004-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4202 The citation records this snapshot. The page link may show a newer release later.	−USD 6.12 million Exact value Exact value: -6120000 USD 2003-08-01 – 2004-07-31: -6120000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2004-07-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -6120000 USD Concept: fundies:OperatingCashFlow Period: 2003-08-01 to 2004-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2004-07-31&surface=latest&period_type=duration&start=2003-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6120000 USD (2003-08-01 to 2004-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4218 The citation records this snapshot. The page link may show a newer release later.	USD 487,000 Exact value Exact value: 487000 USD 2003-08-01 – 2004-07-31: 487000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2004-07-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 487000 USD Concept: fundies:CapitalExpenditure Period: 2003-08-01 to 2004-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2004-07-31&surface=latest&period_type=duration&start=2003-08-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 487000 USD (2003-08-01 to 2004-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4222 The citation records this snapshot. The page link may show a newer release later.	−USD 6.61 million Calculation and evidence -6120000 − 487000 USD Exact free cash flow: -6607000 USD 2003-08-01 – 2004-07-31: -6120000 USD · Inspect Operating Cash Flow · Source 2003-08-01 – 2004-07-31: 487000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2004-07-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -6607000 USD Concept: free-cash-flow Period: 2003-08-01 to 2004-07-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6120000 USD (2003-08-01 to 2004-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4218 Input fundies:CapitalExpenditure: 487000 USD (2003-08-01 to 2004-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001144204-04-019150.txt#4222 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 6.34 million Exact value Exact value: -6341000 USD 2004-01-01 – 2004-12-31: -6341000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2004-12-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -6341000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6341000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-07-000019.txt#14193 The citation records this snapshot. The page link may show a newer release later.	−USD 6.12 million Exact value Exact value: -6120000 USD 2004-01-01 – 2004-12-31: -6120000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2004-12-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -6120000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6120000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-07-000019.txt#14881 The citation records this snapshot. The page link may show a newer release later.	USD 487,000 Exact value Exact value: 487000 USD 2004-01-01 – 2004-12-31: 487000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2004-12-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 487000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 487000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-07-000019.txt#14967 The citation records this snapshot. The page link may show a newer release later.	−USD 6.61 million Calculation and evidence -6120000 − 487000 USD Exact free cash flow: -6607000 USD 2004-01-01 – 2004-12-31: -6120000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 487000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2004-12-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -6607000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6120000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-07-000019.txt#14881 Input fundies:CapitalExpenditure: 487000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-07-000019.txt#14967 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 4.43 million Exact value Exact value: -4429000 USD 2005-01-01 – 2005-12-31: -4429000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2005-12-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -4429000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4429000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#23855 The citation records this snapshot. The page link may show a newer release later.	−USD 3.87 million Exact value Exact value: -3873000 USD 2005-01-01 – 2005-12-31: -3873000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2005-12-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -3873000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3873000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#25719 The citation records this snapshot. The page link may show a newer release later.	USD 116,000 Exact value Exact value: 116000 USD 2005-01-01 – 2005-12-31: 116000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2005-12-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 116000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 116000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#25917 The citation records this snapshot. The page link may show a newer release later.	−USD 3.99 million Calculation and evidence -3873000 − 116000 USD Exact free cash flow: -3989000 USD 2005-01-01 – 2005-12-31: -3873000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 116000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2005-12-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -3989000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3873000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#25719 Input fundies:CapitalExpenditure: 116000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#25917 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 9.46 million Exact value Exact value: -9460000 USD 2006-01-01 – 2006-12-31: -9460000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2006-12-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -9460000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9460000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#23855 The citation records this snapshot. The page link may show a newer release later.	−USD 6.76 million Exact value Exact value: -6764000 USD 2006-01-01 – 2006-12-31: -6764000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2006-12-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -6764000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6764000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#25719 The citation records this snapshot. The page link may show a newer release later.	USD 68,000 Exact value Exact value: 68000 USD 2006-01-01 – 2006-12-31: 68000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2006-12-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 68000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 68000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#25917 The citation records this snapshot. The page link may show a newer release later.	−USD 6.83 million Calculation and evidence -6764000 − 68000 USD Exact free cash flow: -6832000 USD 2006-01-01 – 2006-12-31: -6764000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 68000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2006-12-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -6832000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6764000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#25719 Input fundies:CapitalExpenditure: 68000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-09-000006.txt#25917 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 16.96 million Exact value Exact value: -16963000 USD 2007-01-01 – 2007-12-31: -16963000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2007-12-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -16963000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16963000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-10-000011.txt#11714 The citation records this snapshot. The page link may show a newer release later.	−USD 15.24 million Exact value Exact value: -15240000 USD 2007-01-01 – 2007-12-31: -15240000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2007-12-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -15240000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15240000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-10-000011.txt#12018 The citation records this snapshot. The page link may show a newer release later.	USD 179,000 Exact value Exact value: 179000 USD 2007-01-01 – 2007-12-31: 179000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2007-12-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 179000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 179000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-10-000011.txt#12050 The citation records this snapshot. The page link may show a newer release later.	−USD 15.42 million Calculation and evidence -15240000 − 179000 USD Exact free cash flow: -15419000 USD 2007-01-01 – 2007-12-31: -15240000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 179000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2007-12-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -15419000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15240000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-10-000011.txt#12018 Input fundies:CapitalExpenditure: 179000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-10-000011.txt#12050 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 9.59 million Exact value Exact value: -9586000 USD 2008-01-01 – 2008-12-31: -9586000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2008-12-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -9586000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9586000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9119 The citation records this snapshot. The page link may show a newer release later.	−USD 5.53 million Exact value Exact value: -5533000 USD 2008-01-01 – 2008-12-31: -5533000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2008-12-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -5533000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5533000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9391 The citation records this snapshot. The page link may show a newer release later.	USD 121,000 Exact value Exact value: 121000 USD 2008-01-01 – 2008-12-31: 121000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2008-12-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 121000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 121000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9437 The citation records this snapshot. The page link may show a newer release later.	−USD 5.65 million Calculation and evidence -5533000 − 121000 USD Exact free cash flow: -5654000 USD 2008-01-01 – 2008-12-31: -5533000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 121000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2008-12-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -5654000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5533000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9391 Input fundies:CapitalExpenditure: 121000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9437 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 7.58 million Exact value Exact value: -7577000 USD 2009-01-01 – 2009-12-31: -7577000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2009-12-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -7577000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7577000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9119 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Exact value Exact value: -1578000 USD 2009-01-01 – 2009-12-31: -1578000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2009-12-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -1578000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1578000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9391 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2009-12-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9437 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Calculation and evidence -1578000 − 0 USD Exact free cash flow: -1578000 USD 2009-01-01 – 2009-12-31: -1578000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2009-12-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -1578000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1578000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9391 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9437 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 2.67 million Exact value Exact value: -2666000 USD 2010-01-01 – 2010-12-31: -2666000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVADEL PHARMA INC · 2010-12-31 NOVADEL PHARMA INC (edgar:1043873) Net Income: -2666000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2666000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9119 The citation records this snapshot. The page link may show a newer release later.	−USD 3.28 million Exact value Exact value: -3280000 USD 2010-01-01 – 2010-12-31: -3280000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVADEL PHARMA INC · 2010-12-31 NOVADEL PHARMA INC (edgar:1043873) Operating Cash Flow: -3280000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3280000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9391 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVADEL PHARMA INC · 2010-12-31 NOVADEL PHARMA INC (edgar:1043873) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9437 The citation records this snapshot. The page link may show a newer release later.	−USD 3.28 million Calculation and evidence -3280000 − 0 USD Exact free cash flow: -3280000 USD 2010-01-01 – 2010-12-31: -3280000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVADEL PHARMA INC · 2010-12-31 NOVADEL PHARMA INC (edgar:1043873) Free cash flow: -3280000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:04:12Z Snapshot: 960273285015994e8d776b9624ed7afa234ed568032efb3a8d6bda11217ad990 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1043873?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3280000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9391 Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1043873/0001043873-11-000012.txt#9437 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

66 filings · 203 latest values · 203 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001043873, 1043873, edgar:1043873

Also known as FLEMINGTON PHARMACEUTICAL CORP, NOVADEL PHARMA INC

NOVADEL PHARMA INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation